Cost-effective reimbursement analysis for medical technologies in Europe
Procedure coding, payment mechanism, reimbursement tariffs, policy, and HTA considerations in 20 EU countries
Recent news and posts
Ongoing HTAs by OSTEBA in Spain in February 2024
In February 2024, the Basque Office for Health Technology Assessment (OSTEBA) is working on several HTAs, including evaluations in the cardiovascular, e-health, ENT, IVD, and some other fields. Some examples can be found below:
- Cardiovascular monitoring system that uses photoplethysmography;
- Clinical efficacy and cost-effectiveness of incorporating artificial intelligence into the breast cancer screening program;
- Telemonitoring and computerized management of patients on home dialysis and rehabilitation activities;
- Molecular diagnostic test for multidrug-resistant microorganisms;
- Active piezoelectric bone conduction hearing implant;
- High-intensity focused ultrasound - in essential tremor (update).
The full details in Spanish can be found here.
This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.